When applying for life insurance with AIG, the presence of THC in a drug screening is treated as a component of the overall risk assessment rather than a simple pass-fail binary. AIG, like most major life insurance carriers, utilizes specific medical underwriting guidelines that evaluate marijuana use based on frequency, method of consumption, and the applicant’s overall health profile, rather than relying on a universal, singular "threshold" concentration level.
The Role of Toxicology in Life Insurance Underwriting
Life insurance underwriting is fundamentally a process of risk quantification. When you apply for a policy—whether it is term life, universal life, or whole life—the insurer must determine your life expectancy to set appropriate premiums. A drug test, typically conducted as part of a paramedical examination, serves as an objective verification of the lifestyle disclosures you provide on your application.
For AIG, the laboratory report confirming the presence of cannabinoids (specifically the metabolite THC-COOH) is not viewed in isolation. Underwriters are trained to distinguish between occasional recreational use, medicinal usage, and chronic dependency. Unlike employment-based drug testing, which often looks for a "cutoff" level (commonly 50 ng/mL for initial screening) to determine workplace compliance, life insurance underwriting is more nuanced. Even if your results fall below a standard employment threshold, the presence of any detectable THC can trigger a secondary review of your medical records and application disclosures.
How AIG Categorizes Marijuana Usage
AIG’s underwriting department classifies applicants based on their usage habits. Transparency is the most critical factor in this process. If an applicant admits to using marijuana on their application, the underwriter will likely seek additional information regarding the frequency and purpose of use.
1. Recreational Use
Applicants who use marijuana recreationally are often eligible for coverage. However, frequent recreational use can lead to a "Table Rating," which increases the cost of the premium compared to a "Preferred" or "Standard" rate class. AIG underwriters assess whether the use of the substance is linked to other risky behaviors, such as alcohol consumption or tobacco use, which are often co-morbidities that influence risk stratification.
2. Medicinal Use
If you use THC-based products for a documented medical condition, it is imperative to provide details during the application process. You will need to provide the name of the prescribing physician and the condition being treated. If the marijuana is being used to manage a condition that is otherwise considered high-risk (such as chronic pain, anxiety, or specific neurological disorders), the underwriter will focus on the underlying health issue rather than the drug itself.
3. Frequency and Method
The method of ingestion is a significant factor. Inhaling any substance, including marijuana smoke, can be viewed similarly to tobacco use by some underwriters due to the potential long-term impact on pulmonary health. Edibles, oils, or tinctures may be viewed differently than smoking, as they do not carry the same respiratory risks. Frequent, daily use is scrutinized more heavily than intermittent, monthly usage, as it may suggest a higher potential for substance-related complications.
The Paramedical Exam: What to Expect in 2026
In 2026, the medical examination process for AIG life insurance remains a standard requirement for many applicants, particularly those seeking higher death benefit amounts or those in older age brackets. This exam is typically performed by a third-party service and involves a collection of blood and urine samples.
When you provide a urine sample, the laboratory performs a multi-panel drug screen. While AIG does not publicly disclose their internal "cutoff" sensitivity, these labs utilize industry-standard mass spectrometry to identify metabolites. If THC is detected, the laboratory reports the finding to the insurer. The underwriter then compares these findings against your self-reported usage. If you indicated you were a non-user, but the test returns positive, this creates a "disclosure discrepancy." Such discrepancies are often more damaging to an application than the actual usage of the drug, as they can lead to an outright denial due to perceived lack of candor.
Comparative Underwriting Risk Factors
The following table summarizes how various factors generally influence an AIG underwriting decision regarding marijuana usage. Note that individual results vary based on the total health profile.
| Factor | Lower Risk (Potential for Standard/Preferred) | Higher Risk (Potential for Table Rating/Declined) |
|---|---|---|
| Frequency | Rare (e.g., 1-2 times per year) | Daily or multiple times per week |
| Method | Edibles, tinctures, or oils | Frequent smoking or vaping |
| Disclosure | Fully disclosed at time of application | Undisclosed; discovered via lab test |
| Purpose | Recreational (Low frequency) | Medical (with untreated/unstable condition) |
| Co-usage | No tobacco or heavy alcohol use | Concurrent tobacco use or hazardous habits |
The Impact of Disclosure Discrepancies
A common mistake applicants make is assuming that because marijuana is legal in their specific state or jurisdiction, they do not need to disclose it on a federal or national insurance application. This is a critical error. Life insurance companies operate under their own internal risk guidelines.
If you fail to disclose marijuana use and the laboratory screening detects it, your file will likely be flagged for "misrepresentation." Underwriting teams are tasked with verifying the accuracy of your application. When a discrepancy appears, the underwriter may request a follow-up interview, require medical records from your primary care physician, or simply issue a decline. Even if you are not declined, a finding of misrepresentation often disqualifies you from the most favorable premium tiers, regardless of your other health metrics.
Next Steps for Applicants
If you are currently using THC and are preparing to apply for life insurance with AIG, follow these professional recommendations to navigate the process effectively:
- Be Transparent: Always answer the "Do you use marijuana?" question truthfully. If you are a medical user, provide the name of your doctor and the condition for which it is prescribed.
- Understand Your Health Profile: Recognize that your total health picture—cholesterol, blood pressure, BMI, and family history—often weighs more heavily than occasional marijuana use.
- Prepare Medical Records: If your marijuana use is for a medical condition, ensure your medical records are up to date and clearly document the treatment plan. This helps the underwriter see that your usage is being managed under professional guidance.
- Consider Timing: If you are a light or infrequent user, some financial advisors recommend abstaining for a period before your paramedical exam to ensure your toxicology results reflect your status accurately, though this should never be used as a way to hide chronic, frequent use.
- Work with a Licensed Broker: An independent insurance agent familiar with AIG’s underwriting guidelines can help you present your case effectively. They can assist in gathering the necessary disclosures and help you understand whether your specific frequency of use is likely to impact your rate class.
Frequently Asked Questions
1. Does a positive THC test automatically mean my insurance application will be denied? No. AIG, like many other carriers, does not automatically decline applicants based on the presence of THC. The decision is based on a holistic review of your health, the frequency of use, and the method of administration.
2. Is there a specific "legal limit" for THC in life insurance testing? No. Life insurance companies do not adhere to legal limits set by state laws for driving or employment. Their tests are designed to detect the presence of metabolites for clinical assessment purposes, and they make internal decisions based on risk tolerance rather than legal thresholds.
3. Does medical marijuana use change how AIG views my application? Medical use is viewed differently than recreational use, but it still requires scrutiny. You must disclose it and provide documentation from your physician. The underwriter will then evaluate the underlying condition the marijuana is being used to treat.
4. If I test positive for THC, will my premiums always be higher? Not necessarily. While some underwriters may assign a higher risk rating for frequent users, an occasional user who is otherwise in excellent health may still qualify for favorable rates. It depends on the totality of your application.
5. Should I stop using marijuana before my insurance medical exam? You should consult with your insurance agent. While some may advise abstaining to ensure the test is clear, you must ensure that your disclosures remain accurate. Never lie on an application; it is the most common reason for claims to be denied later.
6. Does AIG differentiate between smoking and other forms of cannabis use? Yes. Inhalation-based usage is often scrutinized more closely due to potential respiratory health implications. Non-smokable forms of consumption may be viewed more favorably by underwriters, provided the frequency of use remains low.
Conclusion and Recommendations
The primary takeaway for any applicant navigating the AIG life insurance process is that honesty is your most valuable asset. The "threshold" you should be most concerned about is not the parts-per-billion level in your toxicology screen, but the threshold of transparency in your application. By proactively disclosing your usage habits and providing clear medical documentation where appropriate, you allow the underwriter to make an informed decision based on your complete health profile.
If you are uncertain about your eligibility, consult with a licensed life insurance professional who has experience with AIG’s specific underwriting philosophy. They can help you determine the best way to present your application, ensuring that you receive the most accurate quote possible given your specific lifestyle and medical history.